Tepezza Hearing Loss Lawsuits
Were you or a loved one affected? Get a free case evaluation today.
Case Overview
Tepezza (teprotumumab) is an FDA-approved medication manufactured by Horizon Therapeutics for treating thyroid eye disease (TED). While effective for its intended purpose, patients have reported severe and permanent hearing damage including hearing loss, tinnitus, and auditory disturbances. Studies indicate that a significant percentage of Tepezza patients experience hearing-related side effects that were not adequately warned about.
Health Risks & Injuries
- Permanent hearing loss
- Tinnitus (ringing in the ears)
- Ear fullness or pressure
- Autophony (hearing one's own voice abnormally loud)
- Hyperacusis (sensitivity to sounds)
- Sensorineural hearing loss
- Balance issues
Who Qualifies
- Patients who received Tepezza infusions
- Those who developed hearing loss during or after treatment
- Patients experiencing persistent tinnitus after Tepezza use
- Those who suffered any hearing damage linked to Tepezza treatment
Current Litigation Status
MDL established in the Northern District of Illinois. Lawsuits continue to be filed against Horizon Therapeutics (now part of Amgen). Bellwether trials being prepared. Cases growing as more patients report hearing complications.
Free Case Evaluation
Find out if you qualify for compensation. No fees unless we win your case.
Get Started Now(800) 555-1234
Get Help With Your Tepezza Case
Our experienced attorneys are ready to evaluate your claim. Free consultation, no obligation.